Fri, February 24, 2023

Joseph Stringer Reiterated (VIR) at Strong Buy and Held Target at $32 on, Feb 24th, 2023

Joseph Stringer of Needham, Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $32 on, Feb 24th, 2023.

Joseph has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $30 on, Friday, January 27th, 2023


These are the ratings of the 3 analyists that currently disagree with Joseph


  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $53 on, Thursday, February 23rd, 2023
  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $43 on, Friday, January 27th, 2023
  • Andrew Galler of "Morgan Stanley" Maintained at Sell with Increased Target to $18 on, Friday, November 4th, 2022